Rocket Pharmaceuticals (RCKT) Investor Presentation - Slideshow

Corporate Presentation 1 November 2021 S E E K I N G G E N E T H E R A P Y C U R E S NASDAQ: RCKT 2 Cautionary Statement Regarding Forward-Looking Statements Various statements in this release concerning Rocket's future expectations, plans and prospects, including without limitation, Rocket's expectations regarding its guidance for 2021 in light of COVID-19, the safety, effectiveness and timing of product candidates that Rocket may develop, to treat Fanconi Anemia (FA), Leukocyte Adhesion Deficiency-I (LAD- ...